Impl investor relations
Witryna1 mar 2024 · Global Ship Lease Investor Presentation - Q4 2024 2.3 MB. Archived Events. Year. Date Event Details; Mar 01, 2024 at 10:30 AM EST Global Ship Lease … WitrynaCorporate Profile. Alpine is a clinical-stage specialty pharmaceutical company focused on discovering and developing protein-based immunotherapies targeting the immune synapse to treat cancer and autoimmune/inflammatory diseases. Our proprietary Variant Immunoglobulin Domain™ (“vIgD™”) and Variant Tumor Necrosis Factor Domain™ …
Impl investor relations
Did you know?
WitrynaOur Investment Case ... Download Read online. Investor Contacts. Raghav Gupta-Chaudhary. Investor Relations Director +44 (0)20 7546 8235 [email protected] … Witryna2 mar 2024 · Contact Investor Relations. Direct [USA +1] 858-952-7593 E-mail [email protected]. ... 8:00am - 5:00pm EST. Cardiff Oncology management will participate in a corporate panel discussion and 1x1 investor meetings at the TD Cowen 43rd Annual Health Care Conference, which is taking place at the Boston... B. Riley …
Witryna7 wrz 2024 · SEATTLE, Sept. 07, 2024 (GLOBE NEWSWIRE) -- Impel NeuroPharma, Inc. (NASDAQ: IMPL), a commercial-stage biopharmaceutical company developing …
WitrynaInvestors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary … Witryna17 lut 2024 · Investors. IPO; Financial Calendar; Financial Reports; Share. The Share; Certified advisor; Analyst coverage; Corporate Governance. Board of Directors; …
WitrynaImpel Pharmaceuticals. 201 Elliott Avenue West, Suite 260 Seattle, WA 98119. Phone: 206.568.1466
WitrynaInvestors; Company; Events & Presentations; Events & Presentations Events & Presentations Upcoming Events Date Title; Apr 20, 2024 at 8:00 AM CDT 2024 Annual Meeting of Stockholders. Inspection of Stockholder List 88.3 KB. Add to Outlook. Add to Google Calendar. Apr 25, 2024 at 7:30 AM CDT ... church of st. benedict mohntonWitryna10 mar 2024 · March 03 2024 - 04:01PM. GlobeNewswire Inc. Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, today announced that the Company will participate in two upcoming investor … dewberry apartmentsWitryna3 mar 2024 · Media Relations: Melyssa Weible Elixir Health Public Relations Phone: (1) 386-366-0616 Email: [email protected]. Investor Relations Janhavi … dewberry animal clinicWitrynaOur Investment Case ... Download Read online. Investor Contacts. Raghav Gupta-Chaudhary. Investor Relations Director +44 (0)20 7546 8235 [email protected] Related pages. 2024 Financial Performance. Financial calendar. Quick Links. Our story; Our approach; Responsibility; Investors; Careers; Contact; Menu Item; dewberry apartments in lancaster texasWitryna3 mar 2024 · Impel Pharmaceuticals Inc. Common Stock (IMPL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Skip to main … dewberry architects chicagoWitryna31 mar 2024 · Investor Calendar; Presentations; Financials. SEC Filings; Quarterly Results; Governance. Governance Highlights; Leadership; Board of Directors; … church of st. benedict mohnton paWitrynaThe Investor Relations website contains information about Mission Produce, Inc.'s business for stockholders, potential investors, and financial analysts. dewberry architects dallas